2 completed. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 2 |
Follow HIV I Infection: new trials by email Literature Review of HIV I Infection trials Research Report on HIV I Infection
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study Evaluating the Pharmacokinetics, Efficacy, Safety and Tolerability of CABENUVA CAB + RPV - HIV-1-infection, HIV Infections | Phase 3 | Completed | Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute) | 12 | 2023-01-01 | 2026-07-14 |
| Early Empiric Anti-Mycobacterium Tuberculosis Therapy for Sepsis in Sub-Saharan Africa Immediate anti-TB therapy, Sepsis-specific dose anti-TB therapy - Tuberculosis, HIV I Infection | Phase 3 | Completed | University of Virginia | 437 | 2022-01-05 | 2026-09-09 |
HIV Infections (1) · Sepsis (1) · Tuberculosis (1)
Infections (2) · Actinomycetales Infections (1) · Bacterial Infections (1) · Bacterial Infections and Mycoses (1) · Blood-Borne Infections (1) · Communicable Diseases (1) · Genital Diseases (1) · Gram-Positive Bacterial Infections (1) · Immune System Diseases (1) · Immunologic Deficiency Syndromes (1) · Inflammation (1) · Lentivirus Infections (1) · Mycobacterium Infections (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1)
Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute) (1) · University of Virginia (1)
Tanzania (1) · Uganda (1) · United States (1)
PMID 35667721, PMID 41619753, PMID 41768988
U01AI150508 (1)